Role of p53 in human cancers
AuthorAçıkalın Çoşkun, Kübra
Gök Yurttaş, Asiye
Abay, Elif Cansu
Yeman Kıyak, Bercem
MetadataShow full item record
CitationAçıkalın Çoşkun, K., Tutar, M., Al, M., Gök Yurttaş, A., Abay, E. C., Yürekli, N., Yeman Kıyak, B., Uçar, K., Tutar, Y. (2022). Role of p53 in human cancers. M. Anwar (Ed.), p53 - A Guardian of the Genome and Beyond. https://doi.org/10.5772/intechopen.101961
TP53 codes tumor protein 53-p53 that controls the cell cycle through binding DNA directly and induces reversible cell-cycle arrest. The protein activates DNA repair genes if mutated DNA will be repaired or activates apoptotosis if the damaged DNA cannot be fixed. Therefore, p53, so-called the “guardian of the genome,” promote cell survival by allowing for DNA repair. However, the tumor-suppressor function of p53 is either lost or gained through mutations in half of the human cancers. In this work, functional perturbation of the p53 mechanism is elaborated at the breast, bladder, liver, brain, lung cancers, and osteosarcoma. Mutation of wild-type p53 not only diminishes tumor suppressor activity but transforms it into an oncogenic structure. Further, malfunction of the TP53 leads accumulation of additional oncogenic mutations in the cell genome. Thus, disruption of TP53 dependent survival pathways promotes cancer progression. This oncogenic TP53 promotes cell survival, prevents cell death through apoptosis, and contributes to the proliferation and metastasis of tumor cells. The purpose of this chapter is to discuss the contribution of mutant p53 to distinct cancer types.
Sourcep53 - A Guardian of the Genome and Beyond
Showing items related by title, author, creator and subject.
Delivery of curcumin within emulsome nanoparticles enhances the anti‑cancer activity in androgen‑dependent prostate cancer cell Background Curcumin, a dietary polyphenol isolated from turmeric, is a potent phytochemical possessing intrinsic anticancer activities against various cancer types including prostate cancer. However, low water solubility ...
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer Goldfarb, Shari B.; Turan, Volkan; Bedoschi, Giuliano; Taylan, Enes; Abdo, Nadia; Cigler, Tessa; Bang, Heejung; Patil, Sujita; Dickler, Maura N.; Oktay, Kutluk H. (Springer, 2021)Purpose To determine the longitudinal impact of adjuvant chemotherapy and tamoxifen-only treatments on the reproductive potential of women with breast cancer by using a sensitive ovarian reserve marker anti-Mullerian hormone ...
Recently, studies on the effects of non-toxic substances on cancer prophylaxis have gained value as an alternative to existing treatment options. Current studies have shown that succinic acid or its derivatives exhibit ...